WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kermer, P.
Right arrow Articles by Bähr, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kermer, P.
Right arrow Articles by Bähr, M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 15, 2000, 20(2):722-728

Insulin-Like Growth Factor-I Protects Axotomized Rat Retinal Ganglion Cells from Secondary Death via PI3-K-Dependent Akt Phosphorylation and Inhibition of Caspase-3 In Vivo

Pawel Kermer, Nikolaj Klöcker, Monika Labes, and Mathias Bähr

Department of Neurology, Medical School, University of Tübingen, 72076 Tübingen, Germany

Recently we have shown that the majority of retinal ganglion cells (RGCs) dies via activation of caspase-3 after transection of the optic nerve (ON) in the adult rat. In the present study we investigated whether insulin-like growth factor-I (IGF-I), an important factor in retinal development, prevents secondary death of RGCs after axotomy. Moreover, we studied potential intracellular mechanisms of IGF-mediated neuroprotection in more detail. Our results indicate that intraocular application of IGF-I protects RGCs from death after ON transection in a dose-dependent manner. We show reduced caspase-3 activity as one possible neuroprotective mechanism of IGF-I treatment in vivo. Caspase-3 mRNA expression remained unchanged. Because caspase inhibition can be mediated by Akt in vitro, we examined phosphorylation of Akt after axotomy and under IGF treatment. Western blot analysis revealed decreased Akt phosphorylation after axotomy without treatment and an increased phosphorylation of Akt under treatment with IGF-I. This strong increase could be reduced by simultaneous injection of wortmannin (WM), a potent inhibitor of phosphatidylinositol 3-kinase (PI3-K). To prove the pathway suggested by these experiments as relevant for the in vivo situation, we assessed the number of RGCs 14 d after ON transection under a combined treatment strategy of IGF-I and WM. As expected, WM significantly reduced the neuroprotective effects of IGF-I. In summary, we show for the first time in vivo that IGF is neuroprotective via PI3-K-dependent Akt phosphorylation and by inhibition of caspase-3.

Key words: insulin-like growth factor-I; retinal ganglion cells; neuroprotection; PKB/Akt; PI3-K; caspase-3; apoptosis

Copyright © 2000 Society for Neuroscience  0270-6474/00/202722-07$05.00/0


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
X. Zhou, F. Li, L. Kong, H. Tomita, C. Li, and W. Cao
Involvement of Inflammation, Degradation, and Apoptosis in a Mouse Model of Glaucoma
J. Biol. Chem., September 2, 2005; 280(35): 31240 - 31248.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Digicaylioglu, G. Garden, S. Timberlake, L. Fletcher, and S. A. Lipton
Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I
PNAS, June 29, 2004; 101(26): 9855 - 9860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. E. N. Reiter, L. Sandirasegarane, E. B. Wolpert, M. Klinger, I. A. Simpson, A. J. Barber, D. A. Antonetti, M. Kester, and T. W. Gardner
Characterization of insulin signaling in rat retina in vivo and ex vivo
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E763 - E774.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Chaum and H. Yang
Transgenic Expression of IGF-1 Modifies the Proliferative Potential of Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3758 - 3764.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Cheng, P. Sapieha, P. Kittlerova, W. W. Hauswirth, and A. Di Polo
TrkB Gene Transfer Protects Retinal Ganglion Cells from Axotomy-Induced Death In Vivo
J. Neurosci., May 15, 2002; 22(10): 3977 - 3986.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. P. Lafuente, M. P. Villegas-Perez, P. Sobrado-Calvo, A. Garcia-Aviles, J. Miralles de Imperial, and M. Vidal-Sanz
Neuroprotective Effects of {alpha}2-Selective Adrenergic Agonists against Ischemia-Induced Retinal Ganglion Cell Death
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2074 - 2084.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Diem, R. Meyer, J. H. Weishaupt, and M. Bahr
Reduction of Potassium Currents and Phosphatidylinositol 3-Kinase-Dependent Akt Phosphorylation by Tumor Necrosis Factor-{alpha} Rescues Axotomized Retinal Ganglion Cells from Retrograde Cell Death In Vivo
J. Neurosci., March 15, 2001; 21(6): 2058 - 2066.
[Abstract] [Full Text] [PDF]


-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-